BRIEF-Agile therapeutics resubmits new drug application for transdermal contraceptive patch
* Agile therapeutics resubmits new drug application (NDA) for its transdermal contraceptive patch, Twirla®
May 2 Sherwin-williams Co-
* The Sherwin-Williams Company commences exchange offers and consent solicitations
* Sherwin-Williams -in connection with anticipated combination of sherwin-williams and valspar, commenced offers to exchange notes issued by valspar Source text for Eikon: Further company coverage:
* Dimension Therapeutics completes strategic review and updates corporate priorities
June 27 U.S. stock index futures were lower on Tuesday as a selloff in technology shares continued, while investors awaited clues on interest rate hikes from Federal Reserve Chair Janet Yellen's talk in London.